Covered recipient · General Payments record
NATALIE N CAPLINGER
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2022–2024
$1,638.20
- Reported across 78 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $577.74 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | $147.24 | 2 |
| PFIZER INC. | $104.52 | 5 |
| Novo Nordisk AS | $99.20 | 5 |
| ABBVIE INC. | $51.79 | 3 |
| Amgen Inc. | $51.11 | 3 |
| Renalytix AI, Inc. | $48.97 | 3 |
| Exact Sciences Corporation | $35.55 | 2 |
| Lilly USA, LLC | $22.14 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $17.22 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.30 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103413907 | CMS |
| ABBVIE INC. | $13.11 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103413909 | CMS |
| ABBVIE INC. | $17.38 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103413911 | CMS |
| Amgen Inc. | $19.72 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117520553 | CMS |
| Amgen Inc. | $14.88 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117520555 | CMS |
| Amgen Inc. | $16.51 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117520557 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $17.22 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086222006 | CMS |
| Exact Sciences Corporation | $16.41 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114607048 | CMS |
| Exact Sciences Corporation | $19.14 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114607052 | CMS |
| Lilly USA, LLC | $22.14 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135283048 | CMS |
| Novo Nordisk Inc | $15.65 | 01/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097366653 | CMS |
| Novo Nordisk Inc | $16.64 | 02/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096815310 | CMS |
| Novo Nordisk Inc | $23.98 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097561539 | CMS |
| Novo Nordisk Inc | $17.93 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096844817 | CMS |
| Novo Nordisk Inc | $25.00 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097812972 | CMS |
| PFIZER INC. | $19.19 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131540343 | CMS |
| PFIZER INC. | $20.52 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131578005 | CMS |
| PFIZER INC. | $25.06 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131461155 | CMS |
| PFIZER INC. | $20.21 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131508934 | CMS |
| PFIZER INC. | $19.54 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131528563 | CMS |
| Phathom Pharmaceuticals, Inc. | $83.62 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151045636 | CMS |
| Phathom Pharmaceuticals, Inc. | $63.62 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151045638 | CMS |
| Renalytix AI, Inc. | $13.69 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116758616 | CMS |
| Renalytix AI, Inc. | $21.49 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116758618 | CMS |
| Renalytix AI, Inc. | $13.79 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116758620 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.